Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein

Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein

The urgent need for vaccines against Ebola virus (EBOV) was underscored by the large outbreak in West Africa (2014–2016). Since then, several promising vaccine candidates have been tested in pre-clinical and clinical studies. As a result, two vaccines were approved for human use in 2019/2020, of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kupke, Alexandra, Dietzel, Erik, Schmidt, Jörg, Shams-Eldin, Hosam, Sauerhering, Lucie, Krähling, Verena, Gellhorn Serra, Michelle, Eickmann, Markus, Becker, Stephan
Formato: Artículo
Lenguaje:inglés
Publicado: Philipps-Universität Marburg 2023
Materias:
correlates of protection; nucleoprotein
vaccine
Modified Vaccinia virus Ankara
Ebola virus
glycoprotein
Medizin
Medical sciences Medicine
Acceso en línea:Texto Completo PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Publikationen im Open Access gefördert durch die UB

Ejemplares similares